Top Suppliers:I want be here

5545-17-5

5545-17-5 structure
5545-17-5 structure
  • Name: N,N'-Diacetyl-L-cystine
  • Chemical Name: (ac-cys-oh)2
  • CAS Number: 5545-17-5
  • Molecular Formula: C10H16N2O6S2
  • Molecular Weight: 324.374
  • Catalog: Biochemical Amino acids and their derivatives Other amino acid derivatives
  • Create Date: 2018-06-20 05:53:28
  • Modify Date: 2026-07-02 11:03:57
  • N,N'-diacetyl-L-cystine (DiNAC) is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine is a potent, orally active modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits[1][2].

Name (ac-cys-oh)2
Synonyms Acetylcysteine Disulfide Dimer
N-acetyl-L-cystine
DiNAC
Acetylcysteine impurity C (A0152000)Q: What is Acetylcysteine impurity C (A0152000) Q: What is the CAS Number of Acetylcysteine impurity C (A0152000)
Acetylcysteine Impurity 38
N,N-diacetylcystine
L-Cystine,N,N'-diacetyl
(AC-CYS-OH)2 //BP
N-ACETYL CYSTINE
(Ac-L-Cys-OH)2
N-ALPHA-ACETYL-L-CYSTINE
N,N'-diacetyl-cystine
ACETYL-L-CYSTINE
(2R)-3-{[(2R)-2-cboxy-2-acetamidoethyl]disulfanyl}-2-acetamidopropanoic acid
Acetylcysteine IMpurity C
(AC-CYS-OH)2
N,N'-Diacetyl-L-Cystine
L-Cystine, N,N'-diacetyl
Acetylcysteine Impurity 5(Acetylcysteine Impurity C)
N,N''-Diacetyl-L-cysteine
Acetylcysteine impurity C CRS
Acetyl Cysteine BP Impurity C
diacetylcysteine
(2R,2'R)-3,3'-disulfanediylbis(2-acetamidopropanoic acid)
3,3'-Dithiobis[(R)-2-acetylaminopropionic acid]
(Ac-L-Cys-OH)2(Disulfide bond) , Chiral purity)
N,N`-Diacetyl-L-cystine
N,N’-Diacetyl-L-cystine
(Ac-Cys-OH)2 (Disulfide bond)
S-(((R)-2-acetamido-2-cboxyethyl)thio)-N-acetylcysteine
N,N''-Diacetyl-L-cystine, 10 mM in DMSO
ACETYLCYSTEINE IMPURITY C / N,N`-DIACETYL- L-CYSTINE
Description N,N'-diacetyl-L-cystine (DiNAC) is the disulphide dimer of N-acetylcysteine with immunomodulating properties. N,N'-diacetyl-L-cystine is a potent, orally active modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. N,N'-diacetyl-L-cystine also has antiatherosclerotic effects in Watanabe-heritable hyperlipidemic rabbit (WHHL) rabbits[1][2].
Related Catalog
Target

Immunomodulator[1]

In Vivo N,N'-Diacetyl-L-cystine (DiNAC; 0-973.11 μg/kg; oral administration; daily; for 12 weeks; WHHL rabbits) treatment reduces by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels[1]. Animal Model: Male heritable hyperlipidemic rabbit (WHHL) rabbits (10-22 weeks)[1] Dosage: 0 μg/kg, 9.73 μg/kg, or 973.11 μg/kg Administration: Oral administration; daily; for 12 weeks Result: Reduced by 50% thoracic aorta atherosclerosis, without affecting plasma lipid levels.
References

[1]. Wågberg M, et al. N,N'-diacetyl-L-cystine (DiNAC), the disulphide dimer of N-acetylcysteine, inhibits atherosclerosis in WHHL rabbits: evidence for immunomodulatory agents as a new approach to prevent atherosclerosis. J Pharmacol Exp Ther. 2001 Oct;299(1):76-82.

[2]. Särnstrand B, et al. N,N'-Diacetyl-L-cystine-the disulfide dimer of N-acetylcysteine-is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. J Pharmacol Exp Ther. 1999 Mar;288(3):1174-84.

Density 1.5±0.1 g/cm3
Boiling Point 715.5±60.0 °C at 760 mmHg
Melting Point 55-72ºC
Molecular Formula C10H16N2O6S2
Molecular Weight 324.374
Flash Point 386.5±32.9 °C
Exact Mass 324.044983
PSA 183.40000
LogP 0.46
Vapour Pressure 0.0±5.0 mmHg at 25°C
Index of Refraction 1.583
Storage condition -15°C
Stability Moisture Sensitive
HS Code 29225090

~98%

5545-17-5 structure

5545-17-5

Literature: Oba, Makoto; Tanaka, Kazuhito; Nishiyama, Kozaburo; Ando, Wataru Journal of Organic Chemistry, 2011 , vol. 76, # 10 p. 4173 - 4177

~0%

5545-17-5 structure

5545-17-5

Literature: Stamler, Jonathan S.; Loscalzo, Joseph Analytical Chemistry, 1992 , vol. 64, # 7 p. 779 - 785

~%

5545-17-5 structure

5545-17-5

Literature: Journal of Biological Chemistry, , vol. 94, p. 244 Archives of Biochemistry, , vol. 18, p. 379

~22%

5545-17-5 structure

5545-17-5

Literature: Watzig; Dette; Aigner; Wilschowitz Pharmazie, 1994 , vol. 49, # 4 p. 249 - 252

~%

5545-17-5 structure

5545-17-5

Literature: Inorganic chemistry, , vol. 39, # 8 p. 1728 - 1734

~%

5545-17-5 structure

5545-17-5

Literature: Biochemical Journal, , vol. 25, p. 619 Rikagaku Kenkyusho Iho, , vol. 8, p. 647,650 Chem. Zentralbl., , vol. 100, # II p. 2770

~%

5545-17-5 structure

5545-17-5

Literature: Biochemical Journal, , vol. 25, p. 619 Rikagaku Kenkyusho Iho, , vol. 8, p. 647,650 Chem. Zentralbl., , vol. 100, # II p. 2770

~%

5545-17-5 structure

5545-17-5

Literature: Photochemistry and Photobiology, , vol. 71, # 3 p. 273 - 280

~%

5545-17-5 structure

5545-17-5

Literature: Canadian Journal of Chemistry, , vol. 76, # 6 p. 789 - 794
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.